Next-generation computational genetic analysis: Multiple complement alleles control survival after Candida albicans infection

Infection and Immunity

Volumn 79, Issue 11, 2011, Pages 4472-4479

  Peltz, Gary ^a   Zaas, Aimee K ^b   Zheng, Ming ^a   Solis, Norma V ^c   Zhang, Mason X ^d   Liu, Hong Hsing ^a   Hu, Yajing ^a   Boxx, Gayle M ^d   Phan, Quynh T ^c   Dill, David ^e   Filler, Scott G ^c,f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d CALIFORNIA STATE UNIVERSITY   (United States)

^e Stanford University   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S;

ACCURACY; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CHROMOSOME SUBSTITUTION; COMPLEMENT SYSTEM; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HAPLOTYPE BASED COMPUTATION GENETIC MAPPING; HEREDITY; HOST SUSCEPTIBILITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SURVIVAL RATE;

ALLELES; ANIMALS; CANDIDIASIS; CHROMOSOME MAPPING; COMPLEMENT ACTIVATION; COMPUTATIONAL BIOLOGY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; MICE; MICE, INBRED STRAINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80855140162     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05666-11     Document Type: Article

References (61)

1. Ashman, R. B., E. M. Bolitho, and J. M. Papadimitriou. 1993. Patterns of resistance to Candida albicans in inbred mouse strains. Immunol. Cell Biol. 71:221-225.
2. Ashman, R. B., A. Fulurija, and J. M. Papadimitriou. 1997. Evidence that two independent host genes influence the severity of tissue damage and susceptibility to acute pyelonephritis in murine systemic candidiasis. Microb. Pathog. 22:187-192.
3. Ashman, R. B., A. Fulurija, and J. M. Papadimitriou. 1996. Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load. Infect. Immun. 64:1866-1869.
4. Ashman, R. B., et al. 2003. Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice. Microb. Pathog. 34:103-113.
5. Bally, I., et al. 2009. Identification of the C1q-binding sites of human C1r and C1s: a refined three-dimensional model of the C1 complex of complement. J. Biol. Chem. 284:19340-19348.
6. Botto, M., et al. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56-59.
7. Botto, M., et al. 2009. Complement in human diseases: lessons from complement deficiencies. Mol. Immunol. 46:2774-2783.
8. Boxx, G. M., T. R. Kozel, C. T. Nishiya, and M. X. Zhang. 2010. Influence of mannan and glucan on complement activation and C3 binding by Candida albicans. Infect. Immun. 78:1250-1259.
9. Boxx, G. M., C. T. Nishiya, T. R. Kozel, and M. X. Zhang. 2009. Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans. Mol. Immunol. 46:473-480.
10. Brown, J. S., et al. 2002. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc. Natl. Acad. Sci. U. S. A. 99:16969-16974.
11. Butko, P., A. Nicholson-Weller, and M. R. Wessels. 1999. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J. Immunol. 163:2761-2768.
12. Chu, L. F., et al. 2009. From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenet. Genomics 19:193-205.
13. Ejzykowicz, D. E., et al. 2010. Role of Aspergillus fumigatus DvrA in host cell interactions and virulence. Eukaryot. Cell 9:1432-1440.
14. Ferwerda, B., et al. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361:1760-1767.
15. Fraser, D. A., A. K. Laust, E. L. Nelson, and A. J. Tenner. 2009. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. J. Immunol. 183:6175-6185.
16. Fraser, D. A., K. Pisalyaput, and A. J. Tenner. 2010. C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production. J. Neurochem. 112:733-743.
17. Glocker, E. O., et al. 2009. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361:1727-1735.
18. 2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement. J. Biol. Chem. 278:32157-32164.
19. Guo, Y. Y., et al. 2007. In vitro and in silico pharmacogenetic analysis in mice. Proc. Natl. Acad. Sci. U. S. A. 104:17735-17740.
20. Guo, Y. Y., et al. 2006. In silico pharmacogenetics: warfarin metabolism. Nat. Biotechnol. 24:531-536.
21. Harrington, D. P., and T. R. Flemming. 1982. A class of rank test procedures for censored survival data. Biometrika 69:553-566.
22. Hector, R. F., J. E. Domer, and E. W. Carrow. 1982. Immune responses to Candida albicans in genetically distinct mice. Infect. Immun. 38:1020-1028.
23. Hu, Y., et al. 2010. The role of IL-1 in wound biology. I. Murine in silico and in vitro experimental analysis. Anesth. Analg. 111:1525-1533.
24. Hu, Y., et al. 2010. The role of IL-1 in wound biology. II. In vivo and human translational studies. Anesth. Analg. 111:1534-1542.
25. Kamboh, M. I., and R. E. Ferrell. 1987. Genetic studies of low-abundance human plasma proteins. VII. Heterogeneity of the C1S subcomponent of the first complement component. J. Immunogenet. 14:231-238.
26. +-ATPase affects pain sensitivity. Pain 144:294-302.
27. Li, X., et al. 2010. Expression genetics identifies spinal mechanisms supporting formalin late phase behaviors. Mol. Pain 6:11.
28. Liang, D., et al. 2006. A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology 104:1054-1062.
29. Liang, D. Y., G. Liao, G. Lighthall, G. Peltz, and J. D. Clark. 2006. Genetic variants of the P-glycoprotein gene Abcb1b modulate opioid-induced hyperalgesia, tolerance and dependence. Pharmacogenet. Genomics 16:825-835.
30. Liao, G., et al. 2004. In silico genetics: identification of a functional element regulating H2-Ea gene expression. Science 306:690-695.
31. Manderson, A. P., M. Botto, and M. J. Walport. 2004. The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22:431-456.
32. Martens, H. A., et al. 2009. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity. Ann. Rheum. Dis. 68:715-720.
33. Mitchell, D. A., et al. 2002. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J. Immunol. 168:2538-2543.
34. Mullick, A., et al. 2004. Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain. Infect. Immun. 72:5868-5876.
35. Nadeau, J. H., J. B. Singer, A. Matin, and E. S. Lander. 2000. Analysing complex genetic traits with chromosome substitution strains. Nat. Genet. 24:221-225.
36. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
37. Puel, A., et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332:65-68.
38. Racila, E., et al. 2008. A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma. Clin. Cancer Res. 14:6697-6703.
39. Radovanovic, I., A. Mullick, and P. Gros. 2011. Genetic control of susceptibility to infection with Candida albicans in mice. PLoS One 6:e18957.
40. Reilly, C. M., and G. S. Gilkeson. 2002. Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice. Immunol. Res. 25:143-153.
41. Rigby, R. J., M. M. Fernando, and T. J. Vyse. 2006. Mice, humans and haplotypes-the hunt for disease genes in SLE. Rheumatology 45:1062-1067.
42. Rosenmann, H., et al. 2003. A polymorphism in the complement component C1r is not associated with sporadic Alzheimer's disease. Neurosci. Lett. 336:101-104.
43. Rozzo, S. J., et al. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15:435-443.
44. Shepherd, M. G., R. T. Poulter, and P. A. Sullivan. 1985. Candida albicans: biology, genetics, and pathogenicity. Annu. Rev. Microbiol. 39:579-614.
45. Smith, S. B., et al. 2008. Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes. Pharmacogenet. Genomics 18:231-241.
46. Stevens, B., et al. 2007. The classical complement cascade mediates CNS synapse elimination. Cell 131:1164-1178.
47. Thiel, S. 2007. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol. Immunol. 44:3875-3888.
48. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
49. Tregoning, J. S., et al. 2010. Genetic susceptibility to the delayed sequelae of RSV infection is MHC-dependent, but modified by other genetic loci. J. Immunol. 185:5384-5391.
50. van de Veerdonk, F. L., et al. 2011. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365:54-61.
51. Walport, M. J. 2001. Complement. First of two parts. N. Engl. J. Med. 344:1058-1066.
52. Walport, M. J. 2001. Complement. Second of two parts. N. Engl. J. Med. 344:1140-1144.
53. Wang, J., and G. Peltz. Haplotype-based computational genetic analysis in mice, p. 51-70. Computational genetics and genomics: new tools for understanding disease. Humana Press Inc., Totowa, NJ.
54. Waterston, R. H., et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420:520-562.
55. Watson, M. L., et al. 1992. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176:1645-1656.
56. Wetsel, R. A., D. T. Fleischer, and D. L. Haviland. 1990. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'exon. J. Biol. Chem. 265:2435-2440.
57. Winkelstein, J. A. 1984. Complement and the host's defense against the pneumococcus. Crit. Rev. Microbiol. 11:187-208.
58. Zaas, A. K., et al. 2008. Plasminogen alleles influence susceptibility to invasive aspergillosis. PLoS Genet. 4:e1000101.
59. Zhang, M. X., D. M. Lupan, and T. R. Kozel. 1997. Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans. Infect. Immun. 65:3822-3827.
60. Zhang, X., et al. 2011. In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor. Pharmacogenomics J. 11:15-24.
61. Zheng, M., S. S. Shafer, G. Liao, H.-H. Liu, and G. Peltz. 2009. Computational genetic mapping in mice: 'the ship has sailed.' Sci. Transl. Med. 1:3ps4.